Recomendaciones para mejorar el control lipídico. Documento de consenso de la Sociedad Española de Cardiología-Reference-Cited by-同舟云学术

Recomendaciones para mejorar el control lipídico. Documento de consenso de la Sociedad Española de Cardiología

Published:2020-02 Issue:2 Volume:73 Page:161-167
ISSN:0300-8932
Container-title:Revista Española de Cardiología
language:es
Short-container-title:Revista Española de Cardiología

Author:

Escobar Carlos,Anguita Manuel,Arrarte Vicente,Barrios Vivencio,Cequier Ángel,Cosín-Sales Juan,Egocheaga Isabel,López de Sa Esteban,Masana Luis,Pallarés Vicente,Pérez de Isla Leopoldo,Pintó Xavier,González Juanatey José Ramón,Zamorano José Luis

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference39 articles.

1. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines;Stone;J Am Coll Cardiol.,2014

2. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry;Kotseva;Eur J Prev Cardiol.,2019

3. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study;Yusuf;Lancet.,2004

4. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis;Boekholdt;JAMA.,2012

5. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur Heart J.,2017

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics, Physiopathology and Management of Dyslipidemias in Pregnancy: A Narrative Review;Nutrients;2024-09-01

2. Differential Adherence to Free and Single-Pill Combination of Rosuvastatin/Ezetimibe: Findings from a Real-World Analysis in Italy;Advances in Therapy;2024-07-04

3. Uso de nuevas terapias hipolipemiantes en la práctica clínica. Consenso SEC/SEA/SEEN/SEMFYC/SEMERGEN/SEMG/SEN/SEACV/S.E.N.;REC: CardioClinics;2024-07

4. Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias–A report from the European Society of Cardiology Cardiovascular Round Table;Journal of Clinical Lipidology;2024-07

5. Gestión terapéutica con policomprimido CNIC al alta de un primer síndrome coronario agudo en España: el estudio PANDORA;REC: CardioClinics;2024-04